Osteoporosis Clinical Trials in Los Angeles

Showing 21-34 of 34 trials

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

NCT00139685

To evaluate and compare Bone Mineral Density (BMD) in adolescent Depo-Provera Contraceptive Injection (DP150CI) users during depo medroxyprogesterone acetate (DMPA) therapy and following discontinuation of DMPA. Another group electing non-hormonal contraception or abstinence will be recruited as a reference population, across all study sites. The primary variable is BMD, measured by Dual Energy X-ray Absorptiometry (DXA). Secondary variables are: Total Body Composition\& Total Body Calcium (TBC), measured by Dual Energy X-ray Absorptiometry (DXA), and surrogate biologic BMD markers. Safety will be evaluated by adverse event reporting, laboratory evaluations, pregnancies, weight and vital signs.

ContraceptionBone Density

Pfizer350 participantsStarted Apr 1998

Los Angeles, California, United States • Palo Alto, California, United States • Torrance, California, United States +9 more locations

COMPLETED7.3 miles

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

NCT00069004

The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure to highly active antiretroviral therapy (HAART).

HIV InfectionsHIV-Associated Lipodystrophy SyndromeHIV Lipodystrophy Syndrome+4 more

National Institute of Allergy and Infectious Diseases (NIAID)450 participantsStarted Oct 2003

Birmingham, Alabama, United States • Alhambra, California, United States • Long Beach, California, United States +35 more locations

Depo-Provera: Bone Mineral Density and Total Body Calcium in Adolescent DP150CI Users and Non-Hormonal Contraception

A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

Osteoporosis Trials in Other Cities

Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women

Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density

Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture

Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Other Conditions in Los Angeles